HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$2.49
Day range
$2.37 - $2.46
Year range
$2.05 - $11.99
Market cap
57.14M USD
Avg Volume
79.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.69M | -28.52% |
Net income | -4.55M | 29.35% |
Net profit margin | — | — |
Earnings per share | -0.18 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.16M | 52.28% |
Total assets | 14.04M | 50.62% |
Total liabilities | 6.11M | -33.67% |
Total equity | 7.92M | — |
Shares outstanding | 23.71M | — |
Price to book | 7.32 | — |
Return on assets | -73.83% | — |
Return on capital | -124.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.55M | 29.35% |
Cash from operations | -3.74M | 21.72% |
Cash from investing | — | — |
Cash from financing | -29.30K | 73.22% |
Net change in cash | -3.77M | 22.87% |
Free cash flow | -2.02M | 16.88% |
About
Founded
2015
Headquarters
Website
Employees
12
